Skip to main content

Advertisement

Log in

Prognostic value of cardiovascular calcifications in hemodialysis patients: a longitudinal study

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

Cardiovascular calcifications (CVC) are present in up to 70% of non-diabetic dialysis patients. Sparse data are available on predictors of very long-term outcomes of such patients. The Belgrade Aachen Study on Calcification in Hemodialysis patients (BASCH study) aimed to study this using a comprehensive CVC assessment.

Methods

We prospectively analyzed 220 hemodialysis patients followed for a mean of 76 months (median 73 months, range 6–160 months). We compared patients deceased from cardiovascular diseases (CVD) and survivors. Analyses included composite calcification scores (determined by combining ultrasound and X-ray analyses), demographic, clinical and laboratory data and pulse wave velocity (PWV). For survival analysis, patients were divided into group according to quartiles (Q).

Results

Compared to survivors, deceased patients from CVD were significantly older, more frequently hypertensive, had shorter dialysis times per week and lower Kt/V values, and they exhibited lower serum fetuin A, osteoprotegerin and hemoglobin as well as higher CRP levels. Composite calcification and Adragao scores were significantly higher in deceased patients from CVD as was PWV. Mean survival was 101 ± 47 months (Q1), 87 ± 51 month (Q2), 66 ± 48 (Q3) and 54 ± 45 months (Q4), p = 0.000. Cox multivariate regression analysis showed that independent predictors for cardiovascular mortality were composite calcification score in the range of third and fourth quartiles.

Conclusion

Composite calcification score emerged as significant predictors of long-term survival in our group of largely non-diabetic dialysis patient population, finding that should be confirmed by intervention studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Schlieper G, Brandenburg V, Djuric Z et al (2009) Risk factors for cardiovascular calcifications in nondiabetic Caucasian haemodialysis patients. Kidney Blood Press Res 32:161–168

    Article  PubMed  Google Scholar 

  2. Ketteler M, Schlieper G, Floege J (2006) Calcification and cardiovascular health: new insights into an old phenomenon. Hypertension 47:1027–1034

    Article  CAS  PubMed  Google Scholar 

  3. Lanzer P, Boehm M, Sorribas V et al (2014) Medial vascular calcification revisited: review and perspectives. Eur Heart J 35:1515–1525

    Article  PubMed  PubMed Central  Google Scholar 

  4. Brandenburg VM, Sinha S, Specht P et al (2014) Calcific uraemic arteriolopathy: a rare disease with a potentially high impact on chronic kidney disease mineral and bone disorder. Pediatr Nephrol 29:2289–2298

    Article  PubMed  Google Scholar 

  5. Raggi P, Boulay A, Scott CT et al (2002) Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39:695–701

    Article  PubMed  Google Scholar 

  6. London G, Covic A, Goldsmith D et al (2011) Arterial aging and arterial disease: interplay between central hemodynamics, cardiac work, and organ flow-implications for CKD and cardiovascular disease. Kidney Int Suppl 1:10–12

    Article  Google Scholar 

  7. Yoon HE, Chung S, Whang HC, Shin YR et al (2012) Abdominal aortic calcification is associated with diastolic dysfunction, mortality, and nonfatal cardiovascular events in maintenance hemodialysis patients. J Korean Med Sci 27(8):870–875. https://doi.org/10.3346/jkms.2012.27.8.870

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kwon HY, Lee OH, Kim MJ et al (2014) The association between mortality and abdominal aortic calcification and relation between its progression and serum calcium concentration in chronic hemodialysis patients. Kidney Res Clin Pract 33(2):95–102. https://doi.org/10.1016/j.krcp.2014.04.003

    Article  PubMed  PubMed Central  Google Scholar 

  9. Inoue H, Shimizu S, Watanabe K et al (2017) Impact of trajectories of abdominal aortic calcification over 2 years on subsequent mortality: a 10-year longitudinal study. Nephrol Dial Transplant. https://doi.org/10.1093/ndt/gfx253

    Google Scholar 

  10. Schlieper G, Krüger T, Djuric Z et al (2008) Vascular access calcification predict mortality in hemodialysis patients. Kidney Int 74(12):1582–1587. https://doi.org/10.1038/ki.2008.458

    Article  CAS  PubMed  Google Scholar 

  11. Hong D, Wu S, Pu L et al (2013) Abdominal aortic calcification is not superior over other vascular calcification in predicting mortality in hemodialysis patients: a retrospective observational study. BMC Nephrol 14:120. https://doi.org/10.1186/1471-2369-14-120

    Article  PubMed  PubMed Central  Google Scholar 

  12. Adragao T, Pires A, Lucas C et al (2004) A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 19:1480–1488

    Article  PubMed  Google Scholar 

  13. Damjanovic T, Djuric Z, Markovic N, Dimković S, Radojcic Z, Dimkovic N (2009) Screening of vascular calcifications in patients with end-stage renal diseases. Gen Physiol Biophys 28:277–283

    PubMed  Google Scholar 

  14. Ix JH, Shlipak MG, Brandenburg VM et al (2006) Association between human fetuin-A and the metabolic syndrome: data from the heart and soul study. Circulation 113:1760–1767

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Schurgers LJ, Teunissen KJ, Knapen MH et al (2005) Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol 25:1629–1633

    Article  CAS  PubMed  Google Scholar 

  16. Schlieper G (2014) Vascular calcification in chronic kidney disease: not all arteries are created equal. Kidney Int 85:501–503

    Article  CAS  PubMed  Google Scholar 

  17. Floege J, Gillespie IA, Kronenberg F et al (2015) Development and validation of a predictive morality risk score from a European hemodialysis cohort. Kidney Int 87(5):996–1008

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Anker SD, Gillespie IA, Eckardt KU, On behalf the ARO Steering Committee (collaborators) et al (2016) Development and validation of cardiovascular risk scores for hemodialysis patients. Int J Cardiol 216:68–77

    Article  PubMed  Google Scholar 

  19. Haydar AA, Covic A, Colhoun H, Rubens M, Goldsmith DJ (2004) Coronary artery calcification and aortic pulse wave velocity in chronic kidney disease patients. Kidney Int 65:1790–1794

    Article  PubMed  Google Scholar 

  20. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM (2001) Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38:938–942

    Article  CAS  PubMed  Google Scholar 

  21. Zoccali C, London G (2015) Con: vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease. Nephrol Dial Transplant 30:352–357

    Article  CAS  PubMed  Google Scholar 

  22. Brandenburg VM, Sinha S, Specht P, Kettelr M (2014) Calcific uraemic arteriolopathy: a rare disease with a potentially high impact on chronic kidney disease-mineral and bone disorder. Pediatr Nephrol 29(12):2289–2298. https://doi.org/10.1007/s00467-013-2746-7

    Article  PubMed  Google Scholar 

  23. Bover J, Evenepoel P, Urena’Tores P et al (2015) Pro: cardiovascular calcifications are clinically relevant. Nephrol Dial Transplant 30(3):345–351. https://doi.org/10.1093/ndt/gfv020

    Article  CAS  PubMed  Google Scholar 

  24. Ketteler M, Rothe K, Kruger T et al (2011) Mechanisms and treatment of extraosseous calcification in chronic kidney disease. Nat Rev Nephrol 7:509–5016

    Article  CAS  PubMed  Google Scholar 

  25. Schafer C, Heiss A, Schwarz A et al (2003) The serum protein alpha 2-Heremans–Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112:357–366

    Article  PubMed  PubMed Central  Google Scholar 

  26. Dautova Y, Kozlova D, Skepper JN et al (2014) Fetuin-A and albumin alter cytotoxic effects of calcium phosphate nanoparticles on human vascular smooth muscle cells. PLoS ONE 9(5):e97565. https://doi.org/10.1371/journal.pone.0097565 eCollection 2014

    Article  PubMed  PubMed Central  Google Scholar 

  27. Ketteler M, Bongartz P, Westenfeld R et al (2003) Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361(9360):827–833

    Article  CAS  PubMed  Google Scholar 

  28. Ix JH, Chertow GM, Shlipak MG et al (2007) Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the heart and soul study. Circulation 115:2533–2539

    Article  PubMed  PubMed Central  Google Scholar 

  29. Moe SM, Reslerova M, Ketteler M et al (2005) Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 67:2295–2304

    Article  CAS  PubMed  Google Scholar 

  30. Cranenburg EC, Brandenburg VM, Vermeer C et al (2009) Uncarboxylated matrix Gla protein (ucMGP) is associated with coronary artery calcification in haemodialysis patients. Thromb Haemost 101:359–366

    CAS  PubMed  Google Scholar 

  31. Schlieper G, Westenfeld R, Krüger T et al (2011) Circulating nonphosphorylated carboxylated matrix Gla protein predicts survival in ESRD patients. J Am Soc Nephrol 22:387–395

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Kapustin AN, Davies JD, Reynolds JL et al (2011) Calcium regulates key components of vascular smooth muscle cells-derived matrix vesicles to enhance mineralization. Circ Res 109:e1–e12

    Article  CAS  PubMed  Google Scholar 

  33. Hofbauer LC, Schoppet M (2001) Osteoprotegerin: a link between osteoporosis and arterial calcification? Lancet 358:257–259

    Article  CAS  PubMed  Google Scholar 

  34. Eknoyan G, Beck GJ, Cheung AK et al (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347(25):2010–2019

    Article  PubMed  Google Scholar 

  35. Schlieper G, Brandenburg V, Djuric Z et al (2007) Is there a correlation between C-reactive protein and calcification inhibitors with cardiovascular parameters and risk factors in hemodialysis patients? Dtsch Med Wochenschr 132:1820–1824

    Article  CAS  PubMed  Google Scholar 

  36. Floege J, Kim J, Ireland E et al (2011) Serum iPTH, calcium and phosphate, and the risk of mortality in a European hemodialysis population. Nephrol Dial Transplant 26:1948–1955

    Article  CAS  PubMed  Google Scholar 

  37. Davenport A (2015) Will incremental hemodialysis preserve residual renal function and improve patient survival? Semin Dial 28(1):16–19. https://doi.org/10.1111/sdi.12320

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nada Dimkovic.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dimkovic, N., Schlieper, G., Jankovic, A. et al. Prognostic value of cardiovascular calcifications in hemodialysis patients: a longitudinal study. Int Urol Nephrol 50, 939–946 (2018). https://doi.org/10.1007/s11255-018-1821-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-018-1821-1

Keywords

Navigation